Navigation Links
Landauer, Inc. Reports Fiscal 2013 First Quarter Results
Date:2/11/2013

0.52 per diluted share, which is consistent with the first fiscal quarter of 2012.

EBITDA for the fiscal first quarter 2013 was $11.5 million compared with $10.6 million in the comparable prior year period. The increase was due primarily to additional interest expense and depreciation offset slightly by lower tax expense.  Adjusted EBITDA was $12.4 million compared to the prior year period Adjusted EBITDA of $13.5 million. A reconciliation of net income to EBITDA and Adjusted EBITDA is included in the attached financial exhibits.

Radiation Measurement SegmentRadiation Measurement revenues for the first fiscal quarter of 2013 decreased 2.2 percent, or $0.6 million, from the first fiscal quarter of 2012 to $26.4 million.  The decrease in the quarter was primarily due to decreases at international subsidiaries over prior year first fiscal quarter.

Radiation Measurement operating income for the first fiscal quarter of 2013 decreased to $5.3 million, or 16.3 percent, from $6.3 million in the comparable prior year period.  The decrease in operating income was due to increased IT expenses related to the company's IT platform enhancement of $1.2 million, decreased revenues from international subsidiaries of $0.4 million, additional customer service support of $0.5 million, additional manufacturing costs of $0.4 million, which was offset by prior year first quarter acquisition costs of $1.8 million.  Corporate expenses for shared functions are recognized in the Radiation Measurement segment where they have been reported historically.  Acquisition and reorganization costs are not allocated to the segments.  As the Company's business model evolves in increased complexity, management may determine it necessary to change this reporting practice to reflect any appropriate allocations.

Medical Physics SegmentMedical Physics revenues for the first fiscal quarter of 2013 increased 2.0 percent, or $0.2 million,
'/>"/>

SOURCE Landauer, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
2. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
3. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer
4. Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
5. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
6. Allied Healthcare Products Reports Second Quarter Loss
7. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at RnRMarketResearch.com
8. Pharmaceutical Market & Biotechnology Industry 2013 Outlook in New Research Reports at ReportsnReports.com
9. Misonix Reports Financial Results for First Half of Fiscal 2013
10. CareFusion Reports First Half Fiscal 2013 Results
11. Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 ... prospects for leading ophthalmic drug companies  What ... pharma ophthalmic industry ? Visiongain,s brand new report ... opportunities and prospects there. Our 242-page report ... lucrative areas in the industry and the future market ...
(Date:3/27/2015)... 27, 2015 The International Myeloma Foundation (IMF) ... while working toward prevention and a cure – today ... a federal resolution (H. Res. 174) that supports the ... Multiple Myeloma Awareness Month." Currently there are ... more than 110,000 new cases are diagnosed yearly, according ...
(Date:3/27/2015)... March 27, 2015 RnRMarketResearch.com ... therapeutic market research report of 52 pages with ... business intelligence library. The report "Visceral ... the therapeutic development for Visceral Pain, complete with ... drug target, mechanism of action (MoA), route of ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
... Nov. 9 New data from the JUPITER,study ... major cardiovascular (CV) events (defined in this,study as ... hospitalization for unstable angina, or death from CV,causes) ... among men and women,with elevated hsCRP but low ...
... 7 Data from an investigational,open-label, randomized ... alfa) in treating anemia in subjects with ... were presented today at the American Society,of ... dosing groups, including the FDA-approved,three-times-per-week (TIW) regimen, ...
Cached Medicine Technology:CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 2CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 3CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 4CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 2Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 4Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 6
(Date:3/28/2015)... 2015 Genomic medicine experts have sequenced ... for the first time, key information for understanding and ... the newly posted story on the Surviving Mesothelioma ... British Columbia, the British Columbia Cancer Agency, and PhenoPath ... underlying molecular alterations and mutations that can lead to ...
(Date:3/28/2015)... Portland, OR (PRWEB) March 28, 2015 ... in the media regarding recent changes and proposals around ... TV , current and former collegiate student-athletes across a ... experiences and reflect on common challenges. The special panel ... the country in sports ranging from football, track and ...
(Date:3/28/2015)... Healthpointe’s otolaryngologists, medical practitioners who attend ... disorders, are now offering a wide variety of treatments ... characterized by the presence of phantom sounds or ringing ... is a prevalent symptom that can arise due to ... tinnitus can impede a person’s quality of life. , ...
(Date:3/28/2015)... Viejo, California (PRWEB) March 28, 2015 ... announced a new overlay entitled Scratches 5K from Pixel ... grungy scratch effects to any media inside Final Cut ... Studios. “StoryBoard Corporate saves time and is an effective ... media using FCPX Overlay Scratches 5K's intuitive grunge overlays. ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Purity ... dietary supplements announces the release of their revolutionary ... shown in two randomized, double-blind, placebo-controlled clinical studies ... waist and hip size. MuffinStop™ is a combination ... and Garcinia mangostana, fused together to create one ...
Breaking Medicine News(10 mins):Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2
... medicines will no longer be available to Canadians from supermarkets ... are aimed at preventing addicts from making crystal meth. //The ... be affected by the ban which will come into force ... sell about 15 medicines which are of the single ingredient ...
... might soon have a vaccine to combat a disease (cervical ... Merck had submitted details of a cervical cancer vaccine, // ... types of infection with the human papilloma virus (HPV) to ... ,Another vaccine, developed by GlaxoSmithKline wound soon be approved for ...
... Medical Sciences has revealed that early stroke and dementia maybe due ... Incidences of blood pressure at an early age should not be ... a lesser blood flow to it due to hypertension, thus raising ... ,This has been confirmed in as many as 33% ...
... rate of intentional injury. This includes cases like suicide and ... a mental health advocate blames the mental health service or ... higher than that seen in Adelaide. He is calling ... kindly donate money to improve the child and adolescent health ...
... Department of Health Services would be banning Mexican candies with ... high levels of lead// in Mexican candies the Officials ... high amount of lead. It is known that there are ... Government is planning to have stringent quality check testing of ...
... treatment for cancer is a drug or substance that stops ... obliterating// or stopping cancer to spread. ,With the same ... report that a compound related to vitamin A is useful ... preventing or slowing tumour growth in mice prone to lung ...
Cached Medicine News:Health News:Cervical Cancer Vaccine Show Promise In Prevention 2Health News:A treatment for lung cancer: similar to Vitamin A but with few side effects. 2
No. 1. 30 mm conventional blades. Thin well-rounded tips....
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Shaft angled 45 degrees. Manufactured in titanium....
Solid 13.5 mm wide by 5 mm deep blades. Edge of blades serrated. Dull finish....
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Medicine Products: